A bibliometric analysis of sentinel lymph node biopsy in melanoma of the top 90 cited publications.

IF 1 Q4 ONCOLOGY

Melanoma Management Pub Date : 2025-12-01 Epub Date: 2025-04-28 DOI:10.1080/20450885.2025.2494979

Zhen Yu Wong, Aisha Chaudry, Samuel Teklay, Zhen Ning Wong, Oluwatobi Adegboye, Pojsakorn Danpanichkul, Ryan Faderani, Muholan Kanapathy, Afshin Mosahebi

{"title":"A bibliometric analysis of sentinel lymph node biopsy in melanoma of the top 90 cited publications.","authors":"Zhen Yu Wong, Aisha Chaudry, Samuel Teklay, Zhen Ning Wong, Oluwatobi Adegboye, Pojsakorn Danpanichkul, Ryan Faderani, Muholan Kanapathy, Afshin Mosahebi","doi":"10.1080/20450885.2025.2494979","DOIUrl":null,"url":null,"abstract":"Background: This bibliometric analysis aims to describe research trends and assess the methodological quality of the highest-impact SLNB research in melanoma.Methods: We identified the 90 most cited publications on SLNB in melanoma using Web of Science, covering all available journal years (from 2005 to date). The Oxford Center for Evidence-Based Medicine (OCEBM) Levels of Evidence (LOE) were used to assess the methodological quality of each study.Results: The 90 most cited publications on SLNB in melanoma collectively garnered 10,314 citations. Citation counts per publication ranged from 44 to 1,405 (mean 114.6 ± 185.2), with the highest-cited study authored by Professor Donald Morton et al. The majority of publications was classified as LOE 3 (n = 36). The United States of America (USA) led in publication output with 43 articles. Professors Merrick Ross (USA) and John Thompson (Australia) were the leading authors by publication count. The University of Sydney (Australia), University of Texas System, and Anderson Cancer Center (USA) were the top contributing institutions. Annals of Surgical Oncology published most articles.Conclusions: This bibliometric analysis provides a comprehensive overview and valuable reference for future researchers in the field of SLNB in melanoma.","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":"12 1","pages":"2494979"},"PeriodicalIF":1.0000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12039427/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20450885.2025.2494979","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This bibliometric analysis aims to describe research trends and assess the methodological quality of the highest-impact SLNB research in melanoma.

Methods: We identified the 90 most cited publications on SLNB in melanoma using Web of Science, covering all available journal years (from 2005 to date). The Oxford Center for Evidence-Based Medicine (OCEBM) Levels of Evidence (LOE) were used to assess the methodological quality of each study.

Results: The 90 most cited publications on SLNB in melanoma collectively garnered 10,314 citations. Citation counts per publication ranged from 44 to 1,405 (mean 114.6 ± 185.2), with the highest-cited study authored by Professor Donald Morton et al. The majority of publications was classified as LOE 3 (n = 36). The United States of America (USA) led in publication output with 43 articles. Professors Merrick Ross (USA) and John Thompson (Australia) were the leading authors by publication count. The University of Sydney (Australia), University of Texas System, and Anderson Cancer Center (USA) were the top contributing institutions. Annals of Surgical Oncology published most articles.

Conclusions: This bibliometric analysis provides a comprehensive overview and valuable reference for future researchers in the field of SLNB in melanoma.

查看原文本刊更多论文

前90位被引出版物中黑色素瘤前哨淋巴结活检的文献计量学分析。

背景：本文献计量学分析旨在描述研究趋势并评估黑色素瘤中影响最大的SLNB研究的方法学质量。方法：我们使用Web of Science检索了90篇被引用最多的关于黑色素瘤SLNB的论文，涵盖了所有可获得的期刊年份（从2005年至今）。采用牛津循证医学中心（OCEBM）证据水平（LOE）评估每项研究的方法学质量。结果：90篇被引最多的关于黑色素瘤SLNB的论文共被引10314次。每份出版物的引用数从44到1405（平均114.6±185.2）不等，引用率最高的研究由Donald Morton教授等人撰写。大多数出版物被归类为loe3 （n = 36）。美利坚合众国（美国）以43篇文章的出版数量居首位。Merrick Ross教授（美国）和John Thompson教授（澳大利亚）的论文发表量位居前列。悉尼大学（澳大利亚）、德克萨斯大学系统和安德森癌症中心（美国）是贡献最多的机构。Annals of Surgical Oncology发表的文章最多。结论：本文的文献计量学分析为今后SLNB在黑色素瘤中的研究提供了全面的综述和有价值的参考。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Melanoma Management ONCOLOGY-

CiteScore

5.10

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.